CN1163242C - Jingan shierkang capsule and its preparing process - Google Patents

Jingan shierkang capsule and its preparing process Download PDF

Info

Publication number
CN1163242C
CN1163242C CNB001051032A CN00105103A CN1163242C CN 1163242 C CN1163242 C CN 1163242C CN B001051032 A CNB001051032 A CN B001051032A CN 00105103 A CN00105103 A CN 00105103A CN 1163242 C CN1163242 C CN 1163242C
Authority
CN
China
Prior art keywords
ganoderma
endothelium corneum
gigeriae galli
corneum gigeriae
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001051032A
Other languages
Chinese (zh)
Other versions
CN1315195A (en
Inventor
黄亚平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001051032A priority Critical patent/CN1163242C/en
Publication of CN1315195A publication Critical patent/CN1315195A/en
Application granted granted Critical
Publication of CN1163242C publication Critical patent/CN1163242C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention belongs to an oral Chinese patent medicine for treating liver cirrhosis diseases, namely a Jingan shierkang capsule and a preparing method thereof. The present invention is characterized in that the medicine is prepared from the raw materials of the following weight proportion: 10 to 20 of ginseng, 5 to 15 of ganoderma, 2 to 8 of chicken's gizzard membrane, 15 to 25 of notoginseng, 5 to 15 of rabdosia amethystoides and 15 to 70 of royal jelly. The present invention has the functions of great original Qi supplement, Qi replenishment, spleen invigoration, liver nourishment, blood circulation activation, organism immune function reinforcement, microcirculation improvement, etc., and has the effect of liver softness, spleen recovery, heart nourishment and brain strengthening. The medicine is clinically tested by 150 liver cirrhosis patients, and the effective rate reaches above 90%.

Description

Heart tonifying capsule and preparation method thereof
Technical field
The invention belongs to a kind of compound capsule for the treatment of hepatopathy and preparation method thereof, particularly relate to a kind of Chinese patent medicine heart tonifying capsule for oral administration for the treatment of the liver cirrhosis disease and preparation method thereof.
Background technology
Liver cirrhosis is that liver is subjected to the result that prolonged and repeated damage causes liver cell degeneration, necrosis, regeneration and a large amount of proliferations of fibrous tissue, and the appearance prompting liver cirrhosis of ascites has belonged to late period.Hepatopathy is a harm greatly of human health, be known as " world's pertinacious disease ", China is the higher country of hepatopathy morbidity, there is every year the hundreds of thousands of them dead because of suffering from liver cirrhosis, hepatocarcinoma, the medical expert attaches great importance to the development of liver cirrhosis, hepatic ascites medicine, but present employed medicine is cured the symptoms, not the disease mostly, easily repeatedly, curative effect is not obvious.Therefore, seek the expectation that a kind of medicine that can effectively treat the liver cirrhosis disease is not only the patient, medical circle is made great efforts one of problem that solves especially.
Summary of the invention
The purpose of this invention is to provide a kind of compound capsule for the treatment of liver cirrhosis, hepatic ascites disease and preparation method thereof.
Solution of the present invention is on the basis of motherland's medical science to the understanding of liver cirrhosis disease and treatment, clinical practice and research in conjunction with surplus 30 years, pick out from motherland's medical treasure-house that reinforcing is set upright, yin fluid astringing is supporing yang, the wholefood and the food plant medicine of strongly invigorating primordial QI, blood circulation promoting and blood stasis dispelling, the liver benefiting spleen invigorating, by the theory of Chinese medical science prescription, skim the cream off milk, make its performance enhancing human body immunity, microcirculation improvement, soft liver fibrosis, recover liver function, effect such as the ascites that disappears.
Heart tonifying capsule of the present invention is made by following component: (consumption is a weight portion)
Radix Ginseng 10-20 Ganoderma 5-15 Endothelium Corneum Gigeriae Galli 2-8
Radix Notoginseng 15-25 Herba Rabdosiae glaucocalycis 5-15 Lac regis apis 15-70
The preparation capsular formula optimization weight of the present invention (part) ratio range is:
Radix Ginseng 12--17 Ganoderma 6--12 Endothelium Corneum Gigeriae Galli 3--6
Radix Notoginseng 16--23 Herba Rabdosiae glaucocalycis 6--12 Lac regis apis 30--57
The capsular optimum weight of the present invention (part) proportioning is:
Radix Ginseng 15 Ganodermas 10 Endothelium Corneum Gigeriae Galli 5
Radix Notoginseng 20 Herba Rabdosiae glaucocalycis 10 Lac regis apis 40
Radix Ginseng of the present invention is meant the cultivation product of Araliaceae Radix Ginseng Panax ginseng C.A.Meg., and the dry root after steaming has that strongly invigorating primordial QI, multiple arteries and veins take off admittedly, the effect of benefiting QI and nourishing blood, the fine powder that the present invention obtains after pulverizing with Radix Ginseng.
Ganoderma among the present invention is the Herb after clean the drying of Polyporaceae plant Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganoderma japonicum (Fr.) Lioyd.The effect of tranquilizing by nourishing the heart, relieving cough and asthma, benefiting qi and nourishing blood is arranged, also can be used for coronary heart disease, hypertension, hyperlipidemia, hepatitis, tracheitis, and the leukopenia that causes of multiple reason etc.The fine powder that the present invention obtains after pulverizing with Ganoderma.
Endothelium Corneum Gigeriae Galli among the present invention is the cutin inwall of the dry ballast of Phasianidae animal chicken G allus gallus domesticusBrisson, has strengthening the spleen to promote digestion, controlling nocturnal emission with astringent drugs only something lost, treating stranguria calculi dissolving function.The fine powder that the present invention obtains after pulverizing with Endothelium Corneum Gigeriae Galli.
Radix Notoginseng among the present invention is the root of panax araliaceae plant Panax notoginseng (Burk) F.H.Chen, cleans, grinds into fine powder after the drying.Removing stasis to stop bleeding is arranged, the analgesic therapy of invigorating blood circulation, adrenal cortex reinforcing function, regulate carbohydrate metabolism, protect the liver, defying age and antitumor action.
Herba Rabdosiae glaucocalycis among the present invention is the herb of labiate Rabdosia japonica L sodon Glaucocalyx (Maxim) Kudo, the whole intestinal that is good for the stomach is arranged, control inappetence, dyspepsia, but heat-clearing and toxic substances removing, spleen invigorating again, invigorate blood circulation, control gastritis, hepatitis from the beginning of, cold, fever etc.The Herba Rabdosiae glaucocalycis herb that the present invention uses is through fine powder thin clean, that obtain after drying, pulverizing.
Lac regis apis among the present invention is the excretory milky jelly of worker bee glandulae pharyngeae of the insecticide apis cerana Apiscerana Fabricus of honeybee section and the liquid that the Mel configuration forms.Lac regis apis is nutritious, is senior tonic.The function that strengthening by means of tonics, the liver benefiting spleen invigorating are arranged has the enhancing body resistance and promotes growth, promotion hemopoietic function, adjusting cardiac function, adjustment E﹠M function, anticancer, antibiotic, analgesic effect, is life lengthening, anti-senility good merchantable brand.The present invention's Lac regis apis lyophilized powder.
Capsule preparations of the present invention is a raw material with above-mentioned Six-element, and its production method that is prepared into the Chinese medicine capsule employing is:
1, with Radix Ginseng and Radix Notoginseng powder, uses CO 2Supercritical fluid extraction, through decocting liquid, fry in shallow oil after carrying standby;
2, with Herba Rabdosiae glaucocalycis, Ganoderma fine powder, extract 3 times with 70% alcohol heating reflux, each 3 hours, it was standby to merge three extracting solution, and it is standby to reclaim ethanol;
3, Endothelium Corneum Gigeriae Galli thin clean, dry in the shade, be ground into can mistake 200 purpose fine powders standby;
4, it is mixed Radix Ginseng, Radix Notoginseng to be fried in shallow oil the extraction liquid phase of carrying back liquid and Herba Rabdosiae glaucocalycis, Ganoderma, through concentrate, behind the thick paste, mix thoroughly with Endothelium Corneum Gigeriae Galli, Lac regis apis lyophilized powder, drying, mixing, sterilization, after sanitary inspection is qualified, the encapsulated finished product of making 0.5g/ grain ± 10%.
The dosage that the present invention is used for the treatment of is adult every day three times, each 3-5 grain, and be three months a course of treatment, patient can take all the year round.
The present invention has that strongly invigorating primordial QI, replenishing QI to invigorate the spleen, nourishing the liver are invigorated blood circulation, enhancing human body immunity function, microcirculation improvement, can strengthen human body self IL-2, activate NK cell and T, bone-marrow-derived lymphocyte system, can soft liver, multiple spleen, nourish heart, brain-strengthening and have a delicate constitution, disease such as deficiency of both QI and blood, through 150 routine liver cirrhosis clinic trial, effective percentage reaches more than 90%.
Heart tonifying capsule formulation preparation of the present invention is convenient, grow storage period, have no side effect, taking convenience, and it is obvious that liver cirrhosis patient is taken the back curative effect, created new approach for treating the liver cirrhosis disease.
The specific embodiment
Heart tonifying capsule of the present invention takes by weighing raw material (kilogram) by following proportioning:
Radix Ginseng 15 Ganodermas 10 Endothelium Corneum Gigeriae Galli 5
Radix Notoginseng 20 Herba Rabdosiae glaucocalycis 10 Lac regis apis 40
Production method is as follows:
1, with Radix Ginseng and Radix Notoginseng powder, uses CO 2Supercritical fluid extraction, through decocting liquid, fry in shallow oil after carrying standby;
2, with Herba Rabdosiae glaucocalycis, Ganoderma fine powder, extract 3 times with 70% alcohol heating reflux, each 3 hours, it was standby to merge three extracting solution, and it is standby to reclaim ethanol;
3, Endothelium Corneum Gigeriae Galli thin clean, dry in the shade, be ground into can mistake 200 purpose fine powders standby;
4, it is mixed Radix Ginseng, Radix Notoginseng to be fried in shallow oil the extraction liquid phase of carrying back liquid and Herba Rabdosiae glaucocalycis, Ganoderma, through concentrate, behind the thick paste, mix thoroughly with Endothelium Corneum Gigeriae Galli, Lac regis apis lyophilized powder, drying, mixing, sterilization, after sanitary inspection is qualified, the encapsulated finished product of making 0.5g/ grain ± 10%.

Claims (4)

1. a heart tonifying capsule for the treatment of the liver cirrhosis disease is characterized in that it is the medicament of being made by the following weight proportion raw material
Radix Ginseng 10-20 Ganoderma 5-15 Endothelium Corneum Gigeriae Galli 2-8
Radix Notoginseng 15-25 Herba Rabdosiae glaucocalycis 5-15 Lac regis apis 15-70
2. heart tonifying capsule according to claim 1, wherein the weight proportion of each raw material is
Radix Ginseng 12-17 Ganoderma 6-12 Endothelium Corneum Gigeriae Galli 3-6
Radix Notoginseng 16-23 Herba Rabdosiae glaucocalycis 6-12 Lac regis apis 30-57
3. heart tonifying capsule according to claim 1, wherein the weight proportion of each raw material is
Radix Ginseng 15 Ganodermas 10 Endothelium Corneum Gigeriae Galli 5
Radix Notoginseng 20 Herba Rabdosiae glaucocalycis 10 Lac regis apis 40
4. according to the preparation method of the described heart tonifying capsule of claim 1, it is characterized in that:
(1) with Radix Ginseng and Radix Notoginseng fine powder CO 2Supercritical fluid extraction, through decocting liquid, fry in shallow oil after carrying standby;
(2) Herba Rabdosiae glaucocalycis, Ganoderma fine powder are extracted three times with 70% alcohol heating reflux, each three hours, it was standby to merge three extracting solution, and it is standby to reclaim ethanol;
(3) Endothelium Corneum Gigeriae Galli is cleaned, dries in the shade, is ground into to cross 200 purpose fine powders standby;
(4) it is mixed Radix Ginseng, Radix Notoginseng to be fried in shallow oil the extraction liquid phase of carrying back liquid and Herba Rabdosiae glaucocalycis, Ganoderma, through concentrate, behind the thick paste, mix thoroughly with Endothelium Corneum Gigeriae Galli fine powder, Lac regis apis lyophilized powder, drying, mixing, sterilization, after the assay was approved through sanitary standard, the encapsulated finished product of making 0.5g/ grain ± 10%.
CNB001051032A 2000-03-24 2000-03-24 Jingan shierkang capsule and its preparing process Expired - Fee Related CN1163242C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001051032A CN1163242C (en) 2000-03-24 2000-03-24 Jingan shierkang capsule and its preparing process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001051032A CN1163242C (en) 2000-03-24 2000-03-24 Jingan shierkang capsule and its preparing process

Publications (2)

Publication Number Publication Date
CN1315195A CN1315195A (en) 2001-10-03
CN1163242C true CN1163242C (en) 2004-08-25

Family

ID=4577530

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001051032A Expired - Fee Related CN1163242C (en) 2000-03-24 2000-03-24 Jingan shierkang capsule and its preparing process

Country Status (1)

Country Link
CN (1) CN1163242C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683437B (en) * 2008-09-22 2012-07-11 北京亚东生物制药有限公司 Traditional Chinese medicine composition for soothing liver and strengthening spleen and nourishing qi and promoting blood circulation and preparation method thereof
CN101890111B (en) * 2009-05-22 2012-08-15 北京亚东生物制药有限公司 Chinese medicinal composition for soothing liver, tonifying spleen, boosting qi and quickening blood, and preparation method thereof
CN105815723A (en) * 2016-03-24 2016-08-03 明光市昊昊蜂业有限公司 Bee milk with effect of removing heat to cool blood

Also Published As

Publication number Publication date
CN1315195A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
CN1170588A (en) Pure natural plant human life energy nutritive substrate
CN101513437A (en) Antifatigue Chinese pharmaceutical composition and preparation method thereof
CN102293927A (en) Compound Chinese medicinal preparation with antifatigue and antioxidation effects, and preparation method thereof
CN1207041C (en) Medicine for treating osteoporosis and its preparing process
CN102266487B (en) Kudzuvine root-containing composition for treating hyperlipemia and preparation method and application thereof
CN104489172A (en) Acanthopanax health tea for improving immunity and preparation method thereof
CN1163242C (en) Jingan shierkang capsule and its preparing process
CN105994867A (en) Chocolate with effect of improving immunity and preparation method thereof
CN105902827A (en) Traditional Chinese medicine composition for improving immunity of human body and preparation method thereof
CN1105557A (en) Method for preparation of weight-loosing medicine and its products
CN1143516A (en) Balanced nutritious food-kangfusu and preparing process thereof
CN115040610A (en) Composition and preparation for reducing blood pressure and preparation method
CN1430982A (en) Capsule of astragalus and honey as well as its preparing technique
CN105853689A (en) Application of green plum extract to preparation of health care product for treating osteoporosis
CN106173128A (en) A kind of chocolate with anti-fatigue effect and preparation method thereof
CN1799590A (en) Deer placenta soft capsule and its preparation method
CN101934046B (en) Semifluid extract of deer foetus and preparation method thereof
CN1060349C (en) Menstruation-regulating and speckle-removing capsule and preparation thereof
CN1053111C (en) Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing
CN1259953C (en) Anti aging health caring medicine
CN1047315C (en) Chinese medicine powder capsule for eliminating numbness and preparing method thereof
CN1264592A (en) Medicine for treating ichthyosis and preparing process thereof
CN1060376C (en) Chinese medicine preparation for skin diseases
CN1069531C (en) Chinese medicine compositions and preparation for prevention and treatment of cerebrovascular atherosclerosis and cancer
CN1146434C (en) Growth promoter for Children

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee